Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

M Dominici Laboratory of Cell Biology and Advanced Cancer Therapy, Oncology-Hematology Department, University of Modena and Reggio Emilia, Modena, ItalyCorrespondence[email protected]

, MD,

K Le Blanc Center for Allogeneic Stem Cell Transplantation, Department of Laboratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden

I Mueller Department of Hematology and Oncology, University Children's Hospital, Tuebingen, Germany

I Slaper-Cortenbach Department of Medical Immunology, UMC Utrecht, Utrecht, the Netherlands

Fc Marini Department of Blood and Marrow Transplant, UT-MD Anderson Cancer Center, Houston, TexasUSA

Ds Krause Department of Laboratory Medicine, Yale University School of Medicine, Connecticut, New Haven, USA

Rj Deans Athersys Inc., Cleveland, OhioUSA

A Keating Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute Toronto, Ontario, Canada

Dj Prockop Center for Gene Therapy, Tulane University Health Sciences Center, Louisiana, New Orleans, USA

Em Horwitz Divisions of Stem Cell Transplantation and Experimental Hematology, St Jude Children's Research Hospital, Memphis TennesseeUSA

show all

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date